Results 21 to 30 of about 1,008 (172)
CLOZAPINE TREATMENT IN BIPOLAR AND SCHIZOAFFECTIVE DISORDERS: A RETROSPECTIVE STUDY
Psychiatry and Clinical Psychopharmacology, 2021 Object: The aim of this study is to evaluate the sociodemographic and clinical features and efficacy of clozapine treatment in patients with bipolar disorder (BD) and schizoaffective disorder (SD).
Özen Önen Sertöz +2 more
doaj
Treatment in Postconcussional Syndrome [PDF]
, 2013 Postconcussional syndrome is characterized by somatic, cognitive and psychiatric (emotional, behavioral) symptoms that occur after mild traumatic brain injury. These symptoms usually recover fully within 3-6 months almost in 90% of patients.
Lut Tamam, Necla Keskin
core +1 more source
Clozapine in the Treatment of Tardive Dyskinesia: Three Case Reports
Psychiatry and Clinical Psychopharmacology, 2021 The causes and the pathogenesis of tardive dyskinesia (TD) are not well understood. There is no consistently successful treatment for TD. Symptoms of TD could be suppressed by clozapine.
Özcan UZUN +3 more
doaj
A COMPARISON OF EFFICACY AND SAFETY OF CLOZAPINE AND SULPIRIDE IN TREATMENT-RESISTANT SCHIZOPHRENIA
Psychiatry and Clinical Psychopharmacology, 2021 Object: In this study, a comparison of efficacy and tolerability of clozapine and sulpiride on treatment-resistant-schizophrenia was aimed. Method: Thirty-six in-patients with treatment-resistant schizophrenia, diagnosed according to DSM-IV diagnostic
Hasan Herken +4 more
doaj
Psychiatry and Clinical Psychopharmacology, 2021 Objective: Clozapine is a well-known atypical antipsychotic agent which is especially useful in patients with treatment-resistant schizophrenia, but there is still debate on its potential to cause arrhythmia and sudden death.
Mevhibe N. Tümüklü +8 more
doaj
Combination treatments in schizophrenia
Psychiatry and Clinical Psychopharmacology, 2021 Use of multiple antipsychotic agents in patients with schizophrenia, especially in treatment resistant schizophrenia, is common practice in psychiatry, although most schizophrenia guidelines recommend monotherapy.
Vesile Altınyazar, Nevzat Yüksel
doaj +1 more source
Treatment of Pediatric Bipolar Disorder [PDF]
, 2014 Although once pediatric bipolar disorder had been perceived as a very rarely seen psychiatric disorder, studies conducted within the last two decades revealed that this disorder is more often than assumed.
Ayten Erdogan, Ozhan Yalcin, Sema Kurban
core +1 more source
Pimozide augmentation of clozapin: A case report
Psychiatry and Clinical Psychopharmacology, 2021 Although clozapine is the gold standard in treatment of resistant schizophrenia, it is ineffective at more than 50% of patients and needs augmentation therapies.
Mine Ergelen +2 more
doaj
Augmentation of clozapine with aripiprazole in treatment-resistent schizophrenia: A case report
Psychiatry and Clinical Psychopharmacology, 2021 Clozapine is the treatment of choice for non-responder schizophrenic patients, with beneficial effects in terms of mental state and suicide mortality.
Osman Yıldırım +4 more
doaj
CLOZAPINE USE IN CASE WITH TREATMENT RESİSTANT CATATONIC SCHIZOPHRENIA AND TARDIVE DYSKINESIA
Psychiatry and Clinical Psychopharmacology, 2021 Clozapine use in a case with treatment resistant catatonic schizophrenia and tardive dyskinesia is an alternative treatment with superior efficacy in a substantial proportion of typical antipsychotic treatment-resistant schizophrenic patients.
Turgut Kundakçı
doaj